Development and production of innovative drugs in Russia

The International Forum of the Adam Smith Institute "Development and production of innovative drugs in Russia" will be held in Moscow, November 17-18, 2010. Based on the success of the Russian Pharmaceutical Forum and the CIS Pharmaceutical Forum, this new event will be an important addition to the Adam Smith Institute's portfolio of pharmaceutical forums.

Why is this Forum relevant?The need to develop innovative drugs in Russia cannot be overestimated.

In accordance with the developed strategy for the development of the pharmaceutical industry in Russia for the period up to 2020, Russian medicines should account for at least half of all available on the pharmaceutical market. To achieve such a result, first of all, special attention should be paid to stimulating the development and production of innovative medicines in Russia.

What to expect at the forum in 2010?

In the program, we reflected the wishes, requirements and questions that we received during the market research. The event will take place over two days. More than 40 speakers from among the most respected leaders of leading Russian and international pharmaceutical companies, government officials, CRO (Risk Management Directors, Chief Risk Officers), leading financiers and consultants of the sector will discuss in detail the most important issues on the development of the sector in the current conditions.

The program of the Forum-2010 includes interesting sessions, including:Creating conditions and mechanisms for the innovative development of the Russian pharmaceutical industry: what are the goals set for the sector today, and what has been done to achieve them?

• Prospects for creating a market for own innovative biotechnological drugs in Russia: strategies and trends
  The possibility of conducting R&D in Russia for foreign players – problems and opportunities 
• Legal issues of R&D in Russia and the creation of a regulatory framework for innovative technologies in the Russian pharmaceutical industry: the creation and improvement of the "Innovation Code", patent protection, data exclusivity, etc.
• Creation and development of clusters of the modern pharmaceutical industry: what are the prospects for the development of the modern innovation ecosystem in Russia?
• Special focus "Clinical research in Russia: present and future" – two sessions devoted to the discussion of the regulation of the sector and practical aspects of clinical trials in Russia

When preparing the forum program, we will rely not only on the results of traditional market research and a substantive survey of industry experts, but also on the opinion of the forum's Advisory Board.

Already today, the advisory board includes the following experts:

• Gennady Shirshov, Executive Director, Union of Professional Pharmaceutical Organizations
• Andrew Somers, President of the American Chamber of Commerce in Russia
• Sergey Kolesnikov, Deputy Chairman of the State Duma Committee on Health Protection and President of the National Chamber of Innovation and Technology
• Dmitry Morozov, Chairman of the Board of Directors of Biocad
• Mikhail Mogutov, President of Bioprocess Holding and Bioprocess Group of Companies
• Irina Dorokhova, Director of Johnson & Johnson for Relations with government Organizations in Russia and Central and Eastern Europe
• Svetlana Zavidova, Executive Director of the Association of Clinical Research Organizations (AOKI)
• Olga Morozova, Director of the company "Eli Lilly Russia" for relations with public and professional organizations

To find out about sponsorship or exhibition opportunities and how you can most profitably present your company at the forum, please contact Irina Norris by phone: + 44 207-017-7436 or by e-mail irina@adamsmithconferences.comGiven the constantly changing situation, there are questions that would be interesting for the participants of the sector to discuss.

If you have any suggestions regarding issues that require discussion, please contact the project manager Inna Kuzmina by e-mail innak@adamsmithconference.com , or by phone: 44 (0) 207-017-6599

Details are available on the forum's website.